All In MedTech

Device Trial Radar · NCT01106417

Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion

Phase 2 Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion With Anterior Cervical Plate Fixation

Last checked: Nov 19, 2026Latest source record: Jun 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Jun 2010

Primary completion

May 2012

Study completion Mar 2013

Sponsor

Lead sponsor
Mesoblast, Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Apr 19, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and preliminary efficacy of NeoFuse in subjects with a diagnosis of degenerative disc disease (DDD) at 2 or more adjacent cervical vertebral levels between C3-C4 to C7-T1. All subjects in this study will undergo 2 or 3 level anterior cervical discectomy and fusion with Anterior Cervical Plate Fixation.

Conditions

  • Cervical Degenerative Disc Disease
  • Degenerative Spondylolisthesis
  • Spinal Stenosis

Interventions

  • NeoFuseBiological

    Single Dose NeoFuse Surgical Implantation

  • MasterGraft GranulesDevice

    Single Dose MaterGraft Granules Surgical Implantation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of NeoFuseTime frame: 2 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Monash Medical Centre

    Clayton, Victoria, Australia

  • Royal Melbourne Hospital

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.